Highlights:,Baird upgraded McKesson Corporation’s stock from Neutral to Outperform, raising its price target to $688 from $531.,McKesson's strong performance in the U.S. Pharmaceutical Distribution ...

More than six weeks after Baltimore opened its civil case against a pair of drug distribution companies, the trial is nearing a conclusion.

McKesson Corp (MCK) reports a 21% revenue increase and raises fiscal 2025 EPS guidance amid strategic expansions and ...

Check out this evening’s top movers from around Wall Street, compiled by The Fly.   HIGHER AFTER EARNINGS – AppLovin ...

Global mHealth Market is valued at approximately USD 83.17 billion in 2023 and is anticipated to grow at a healthy compound annual growth rate (CAGR) of 13.1% during the forecast period from 2024 to ...

Following Donald Trump's election night victory, many publicly traded businesses in Dallas-Fort Worth saw a rise in stock ...

McKesson (MCK) reported $93.65 billion in revenue for the quarter ended September 2024, representing a year-over-year increase of 21.3%. EPS of $7.07 for the same period compares to $6.23 a year ago.

Drug distributor McKesson Corp raised its annual profit forecast on Wednesday, driven by increased sales in its U.S.

Grant Bancshares, Inc., the holding company for BOM Bank, has successfully completed a private placement of $70 million in fixed-floating-rate subordinated notes due December 31, 2034. This funding ...

Deluxe , a Trusted Payments and Data company, today announced its third quarter 2024 financial results through an earnings release available on the company's Investor Relations website at The ...

McKesson Corporation (NYSE: MCK) has released its fiscal 2025 second quarter financial results. Results can be accessed on ...

IRVING, Texas (AP) — IRVING, Texas (AP) — McKesson Corp. (MCK) on Wednesday reported fiscal second-quarter net income of $241 million. The Irving, Texas-based company said it had net income of $1.87 ...